New research that was conducted by Hadassah Ein Kerem Hospital in Jerusalem together with Israeli company BrainStorm Cell Therapeutics has been generating a lot of attention globally due to its abilities that were proven in a recent trial.
During the 4-year trial, 26 ALS (amyotrophic lateral sclerosis, or Lou Gehrig’s disease) patients were treated with new and groundbreaking technology. The experimental treatment was based on gathering stem cells from a patient’s own bone marrow and then, by using a special technique, the stem cells were returned back to the patient’s spinal fluid, after they were treated in a lab.
“We saw an improvement in 90 percent of the patients who underwent the trials,” said Director of Multiple Sclerosis Center at Hadassah Ein Kerem Hospital Dr. Dimitrios Karussis. “Motor function returned for many of the patients. There was an improvement in their hands, and their ability to breathe improved.”
All over the world, people were happy to hear the good news about the successful trial. In the US, Dr. Cliff Siegel of the Providence Medical Center stated: “If the research was successful and the same results will be proven among 26 patients in the US, it will most defiantly change ALS for good.” Karussis added: “
Despite the excitement over this new technology, it is still too early to announce that a cure has been discovered for the terrible disease but the new trial is bringing hope to ALS patients and their families.